Request for Information (RFI)
The White House Office of Science and Technology Policy (OSTP) is seeking input on two different initiatives pertaining to biotechnology and biomanufacturing.
RFI #1
The President’s Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy launched a National Biotechnology and Biomanufacturing Initiative (NBBI) to advance biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, and supply chain resilience, and to advance national and economic security. Biotechnology and biomanufacturing offer new opportunities to strengthen supply chains and lower prices, create more sustainable products through bio-based production, expand domestic production of goods and materials, create jobs across all of America, and spur new opportunities in agricultural communities, as some examples.
This RFI seeks public input on how advances in biotechnology and biomanufacturing can help us achieve goals that were previously out of reach and what steps can be taken to ensure we have the right research ecosystem, workforce, data, domestic biomanufacturing capacity, and other components to support a strong bioeconomy. Seeks public input on how advances in biotechnology and biomanufacturing can help us achieve goals that were previously out of reach and what steps can be taken to ensure we have the right research ecosystem, workforce, data, domestic biomanufacturing capacity, and other components to support a strong bioeconomy. The deadline is January 20.
RFI #2
The White House Office of Science and Technology Policy (OSTP) in coordination with the U.S. Environmental Protection Agency (EPA), the Food and Drug Administration (FDA), and the U.S. Department of Agriculture (USDA) announced a request for relevant data and information, including case studies, to help identify regulatory ambiguities, gaps, or uncertainties in the Coordinated Framework for Regulation of Biotechnology, particularly as related to new and emerging biotechnology products.
The information provided will help regulatory agencies improve the clarity and efficiency of the regulatory processes for biotechnology products as described in Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy.” The deadline is February 3.
Bio Nebraska will submit comments on behalf of its member companies. Please provide your input on RFI #1 by January 17 and/or input on RFI #2 by January 31 to Rob Owen at [email protected] to be included in Bio Nebraska’s comments. Companies are welcome to submit their own comments as well.